$74.81
0.881.19%
At close: -
$74.81
0.000.00%
After Hours: Dec 20, 7:50 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Edwards Lifesciences (EW) was reported on December 4, 2024 for the full year 2025. The company provided earnings per share guidance in the range of $2.40 to $2.50, compared to the estimated EPS of $2.47. Additionally, Edwards Lifesciences forecasted revenue between $5.60B and $6.00B for the quarter.
Browse guidance and forecast on all stocks.